Karyopharm Therapeutics Grants Stock Options and RSUs to New Employees
Karyopharm Therapeutics Inc. has granted stock options for 2,800 shares and 15,791 RSUs to seven new employees. Stock options have a $5.62 exercise price and vest over four years, while RSUs vest over three years. Vesting is contingent on continued employment. This announcement was made via PR Newswire on December 01, 2025.
Karyopharm Therapeutics Inc. has granted stock options to purchase a total of 2,800 shares of its common stock and 15,791 restricted stock units (RSUs) to seven newly-hired employees. The stock options, with an exercise price of $5.62 per share, vest over four years, with 25% vesting on the one-year anniversary of the employee’s start date and the remainder vesting monthly thereafter. Each RSU award will vest over three years, with one-third vesting on each anniversary of the grant date. Vesting for both stock options and RSUs is contingent on continued employment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE36035) on December 01, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
